Vascular dysfunction: A key player in chronic cardio-renal syndrome

Internal Medicine

Volumn 54, Issue 12, 2015, Pages 1465-1472

  Tomiyama, Hirofumi ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Arterial stiffness; Cardio renal syndrome; Chronic kidney disease; Endothelial function; Heart failure; Pressure wave reflection

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II; ENDOTHELIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RENIN;

ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD VESSEL INJURY; CARDIORENAL SYNDROME; CHRONIC KIDNEY DISEASE; ENDOTHELIAL DYSFUNCTION; HEART AFTERLOAD; HEART FAILURE; HEMODYNAMICS; HUMAN; PERIPHERAL ARTERIAL TONOMETRY; PULSE WAVE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION; ARTERIAL PRESSURE; BLOOD PRESSURE; CAROTID ARTERY; CHRONIC DISEASE; FEMALE; HEART VENTRICLE; MALE; PATHOLOGY; PATHOPHYSIOLOGY;

ARTERIAL PRESSURE; BLOOD PRESSURE; CARDIO-RENAL SYNDROME; CAROTID ARTERIES; CHRONIC DISEASE; FEMALE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; MALE; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84931065009     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.4502     Document Type: Article

References (48)

1. Ronco C, Ronco F. Cardio-renal syndromes: a systematic approach for consensus definition and classification. Heart Fail Rev 17: 151-160, 2012.
2. Waldum B, Os I. The cardiorenal syndrome: what the cardiologist needs to know. Cardiology 126: 175-186, 2013.
3. Hatamizadeh P, Fonarow GC, Budoff MJ, Darabian S, Kovesdy CP, Kalantar-Zadeh K. Cardiorenal syndrome: pathophysiology and potential targets for clinical management. Nat Rev Nephrol 9: 99-111, 2013.
4. Fox CS, Matsushita K, Woodward M, et al; Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 380: 1662-1673, 2012.
5. Mahmoodi BK, Matsushita K, Woodward M, et al; Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 380: 1649-1661, 2012.
6. Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J 74: 24-33, 2010.
7. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 27: 266-274, 2007.
8. Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291: H985-H1002, 2006.
9. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107: 2864-2869, 2003.
10. Japanese Circulation Society. Guidelines for Non-Invasive Vascular Function Test (JCS 2013). In: JCS Joint Working Groups for guidelines for diagnosis and treatment of cardiovascular diseases 2013-2014. Available from: http://www.j-circ.or.jp/guideline/pdf/JC S2013_yamashina_h.pdf (in Japanese).
11. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 115: 1285-1295, 2007.
12. Tomiyama H, Matsumoto C, Yamada J, et al. The relationships of cardiovascular disease risk factors to flow-mediated dilatation in Japanese subjects free of cardiovascular disease. Hypertens Res 31: 2019-2025, 2008.
13. Flammer AJ, Anderson T, Celermajer DS, et al. The assessment of endothelial function: from research into clinical practice. Circulation 126: 753-767, 2012.
14. Safar ME. Arterial stiffness: A simplified overview in vascular medicine. In: Atherosclerosis, Large Arteries and Cardiovascular Risk. Safar ME, Frohlich ED, Eds. Karger, Paris, 2007: 1-18.
15. Reference Values for Arterial Stiffness’ Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J 31: 2338-2350, 2010.
16. Van Bortel LM, Laurent S, Boutouyrie P, et al; Artery Society, European Society of Hypertension Working Group on Vascular Structure and Function, European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotidfemoral pulse wave velocity. J Hypertens 30: 445-448, 2012.
17. Tanaka H, Munakata M, Kawano Y, et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 27: 2022-2027, 2009.
18. O’Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 50: 1-13, 2007.
19. Wohlfahrt P, Krajcoviechová A, Seidlerová J, Mayer O, Filipovsky J, Cífková R. Comparison of noninvasive assessments of central blood pressure using general transfer function and late systolic shoulder of the radial pressure wave. Am J Hypertens 27: 162-168, 2014.
20. Herbert A, Cruickshank JK, Laurent S, Boutouyrie P; Reference Values for Arterial Measurements Collaboration. Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. Eur Heart J 35: 3122-3133, 2014.
21. Fischer D, Rossa S, Landmesser U, et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26: 65-69, 2005.
22. Meyer B, Mörtl D, Strecker K, et al. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol 46: 1011-1018, 2005.
23. Heitzer T, Baldus S, von Kodolitsch Y, Rudolph V, Meinertz T. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. Arterioscler Thromb Vasc Biol 25: 1174-1179, 2005.
24. Toda N, Toda H. Coronary hemodynamic regulation by nitric oxide in experimental animals: recent advances. Eur J Pharmacol 667: 41-49, 2011.
25. Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 60: 1455-1469, 2012.
26. Goligorsky MS. Endothelial cell dysfunction: can’t live with it, how to live without it. Am J Physiol Renal Physiol 288: F871-F880, 2005.
27. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25: 932-943, 2005.
28. Lockhart CJ, Hamilton PK, Quinn CE, McVeigh GE. End-organ dysfunction and cardiovascular outcomes: the role of the microcirculation. Clin Sci (Colch) 116: 175-190, 2009.
29. Odaira M, Tomiyama H, Matsumoto C, et al. Strength of relationships of the pulse wave velocity and central hemodynamic indices with the serum N-terminal fragment B-type natriuretic peptide levels in men: a worksite cohort study. Circ J 76: 1928-1933, 2012.
30. Sharma K, Kass DA. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res 115: 79-96, 2014.
31. Chirinos JA, Kips JG, Jacobs DR Jr, et al. Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis). J Am Coll Cardiol 60: 2170-2177, 2012.
32. Meguro T, Nagatomo Y, Nagae A, et al. Elevated arterial stiffness evaluated by brachial-ankle pulse wave velocity is deleterious for the prognosis of patients with heart failure. Circ J 73: 673-680, 2009.
33. Shantsila E, Wrigley BJ, Blann AD, Gill PS, Lip GY. A contemporary view on endothelial function in heart failure. Eur J Heart Fail 14: 873-881, 2012.
34. Tartière-Kesri L, Tartière JM, Logeart D, Beauvais F, Cohen Solal A. Increased proximal arterial stiffness and cardiac response with moderate exercise in patients withheart failure and preserved ejection fraction. J Am Coll Cardiol 59: 455-461, 2012.
35. Satoh M. Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease. Clin Exp Nephrol 16: 518-521, 2012.
36. Perticone F, Maio R, Perticone M, et al. Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients. Circulation 122: 379-384, 2010.
37. Nakamura T, Obata JE, Hirano M, et al. Endothelial vasomotor dysfunction in the brachial artery predicts the short-term development of early stage renal dysfunction in patients with coronary artery disease. Int J Cardiol 148: 183-188, 2011.
38. Peralta CA, Jacobs DR Jr, Katz R, et al. Association of pulse pressure, arterial elasticity, and endothelial function with kidney functiondecline among adults with estimated GFR >60 mL/min/ 1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 59: 41-49, 2012.
39. O’Rourke MF, Safar ME, Dzau V. The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med 15: 461-468, 2010.
40. Tomiyama H, Tanaka H, Hashimoto H, et al. Arterial stiffness and declines in individuals with normal renal function/early chronic kidney disease. Atherosclerosis 212: 345-350, 2010.
41. Yilmaz MI, Stenvinkel P, Sonmez A, et al. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. Nephrol Dial Transplant 26: 3537-3543, 2011.
42. Lilitkarntakul P, Dhaun N, Melville V, et al. Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity. Atherosclerosis 216: 217-225, 2011.
43. Moody WE, Edwards NC, Madhani M, et al. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association? Atherosclerosis 223: 86-94, 2012.
44. Benetos A, Adamopoulos C, Bureau JM, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 105: 1202-1207, 2002.
45. Utescu MS, Couture V, Mac-Way F, et al. Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study. Hypertension 62: 154-160, 2013.
46. Mörtsell D, Malmqvist K, Held C, Kahan T. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study. J Intern Med 261: 472-479, 2007.
47. Tanaka H, Safar ME. Influence of lifestyle modification on arterial stiffness and wave reflections. Am J Hypertens 18: 137-144, 2005.
48. O’Rourke MF, Adji A, Namasivayam M, Mok J. Arterial aging: a review of the pathophysiology and potential for pharmacological intervention. Drugs Aging 28: 779-795, 2011.